GST appellate authority upholds Aurobindo Pharma ITC order
In short
A GST appellate authority in Hyderabad upheld an order involving a ₹4.6 crore input tax credit claim against Aurobindo Pharma. The order was passed for the 2020-21 financial year under the Central GST Act and Telangana GST Act.
The ruling matters because it affects Aurobindo Pharma’s tax position, but the report does not say whether the company will appeal or what the final cost will be.
What the reporting says
The Appellate Joint Commissioner (ST), Malkajgiri Division, Hyderabad upheld an input tax credit claim order involving ₹4.6 crore against Aurobindo Pharma for the 2020-21 financial year. The order was passed under the Central GST Act and Telangana GST Act. The reporting does not state the full tax dispute details, whether the company will challenge the ruling, or any financial impact beyond the amount cited.
Why it matters
The Appellate Joint Commissioner (ST), Malkajgiri Division, Hyderabad upheld an order tied to Aurobindo Pharma’s ₹4.6 crore input tax credit claim for 2020-21 under the Central GST Act and Telangana GST Act. This is a company-specific tax ruling that could affect the firm’s liabilities, but the report does not say whether the decision is final or contested. The broader financial impact is not stated.